JPRN-UMIN000010543已完成未知
Comparison of metformin and vildagliptin in type 2 diabetes assessed by meal tolerance test - Comparison of metformin and vildagliptin in type 2 diabetes assessed by meal tolerance test
aga Municipal Hospital0 个研究点目标入组 30 人开始时间: 2013年4月22日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who falls under any of the following conditions shall be excluded: (1)Type 1 diabetes or type 2 diabetes with insulin-dependent condition (2)severe renal and liver dysfunction (3)unstable pre or proliferative diabetic retinopathy, severe neuropathy (4)past history of the gastrointestinal tract or pancreas operation (5)administered steroid drugs (6)severe infection (7)pregnant or planned pregnant in the near future (8)ineligible for some other medical reasons judged by the investigator
研究者
相似试验
已完成
4 期
Metformin Versus Vildagliptin for Diabetic Hypertensive PatientsReducing the Elevated Blood Pressure for Diabetic Hypertensive PatientsNCT03253562MTI University120
已完成
不适用
Vildagriptin versus metformin adding to the inadequate controled type 2 diabetes with multiple daily insulin injection (VMAT)Type 2 diabetesJPRN-UMIN000024663Toho University30
终止
4 期
Comparison of Vildagliptin vs. Glimepiride on Glucose Variability in Metformin Uncontrolled Type 2 Diabetic PatientsType 2 Diabetes MellitusNCT01910441Novartis Pharmaceuticals95
已完成
4 期
Study of combination of vildagliptin with metformin and glimepiride with metformin in type2 diabetic patientsCTRI/2022/01/039090avreet Kaur80
Unknown
4 期
Metformin Versus Vildagliptin in Reducing Risk of Metabolic Syndrome Complications ProgressionMetabolic SyndromeDiabete Type 2Kidney InsufficiencyNCT04485845Cairo University39